文献速递免疫规划慢病防控与筛查

鄞州电子健康档案中暴露于选定疫苗的中国儿童健康结局发生率:基于人群的回顾性队列研究

Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou Electronic Health Records: A population-based retrospective cohort study.
PubMed 文献 · Vaccine · 2020-03-13

该研究利用宁波市鄞州区电子健康档案数据库,纳入2012年1月1日至2017年3月31日期间接种至少一剂OPV、DTaP、Hib或DTaP-IPV//PRP~T的0-2岁儿童共220,422名,估计8种健康结局的发生率。接种后0-7天内未观察到呼吸暂停、川崎病和吉兰-巴雷综合征病例;过敏性休克、热性惊厥、全部惊厥、荨麻疹/血管性水肿和哮喘的发生率范围分别为每10万人年0.0至50.0、0.0至99.9、29.1至249.8、297.8至949.1和992.7至2298.2,每10万剂次分别为0.0至0.9、0.0至1.9、0.6至4.6、5.6至17.5和18.7至42.3。部分健康结局发生率与文献可比,部分不可比,作者建议未来研究考虑病历复核以验证电子健康档案中获取的健康结局。

要点

  • 接种后0-7天内未观察到呼吸暂停、川崎病和吉兰-巴雷综合征病例。
  • 过敏性休克发生率为每10万人年0.0至50.0,每10万剂次0.0至0.9。
  • 热性惊厥发生率为每10万人年0.0至99.9,每10万剂次0.0至1.9。

核心结论

  • 本研究中部分健康结局的发生率与文献可比,部分不可比,原因在于研究设计、接种后风险期和疫苗类型的差异。
  • 作者建议未来研究应考虑病历复核以验证电子健康档案中获取的健康结局。

研究设计与样本

  • 基于人群的回顾性队列研究,使用宁波市鄞州区电子健康档案数据库。
  • 纳入2012年1月1日至2017年3月31日期间接种至少一剂OPV、DTaP、Hib或DTaP-IPV//PRP~T的0-2岁儿童,共220,422名。
  • 通过ICD-10编码识别8种健康结局:过敏性休克、热性惊厥、全部惊厥、哮喘、呼吸暂停、川崎病、荨麻疹/血管性水肿、吉兰-巴雷综合征。

主要发现

  • 接种后0-7天内未观察到呼吸暂停、川崎病和吉兰-巴雷综合征病例。
  • 接种后0-7天内,过敏性休克发生率为每10万人年0.0至50.0,每10万剂次0.0至0.9。
  • 接种后0-7天内,热性惊厥发生率为每10万人年0.0至99.9,每10万剂次0.0至1.9。
  • 接种后0-7天内,全部惊厥发生率为每10万人年29.1至249.8,每10万剂次0.6至4.6。
  • 接种后0-7天内,荨麻疹/血管性水肿发生率为每10万人年297.8至949.1,每10万剂次5.6至17.5。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Oral poliovirus vaccine (OPV) and diphtheria-tetanus-acellular pertussis vaccine (DTaP) are widely used in China while Haemophilus influenzae type b vaccines (Hib) and a DTaP, inactivated poliovirus (IPV) andHib polysaccharide conjugated to tetanus protein (PRP ~ T) combined vaccine (DTaP-IPV//PRP ~ T) have lower coverage. There are limited safety data on these vaccines in Chinese pediatric populations. METHODS: To estimate incidence rates (IRs) of health outcomes of interest (HOIs) among children exposed to OPV, DTaP, Hib, and DTaP-IPV//PRP ~ T, we conducted a retrospective cohort study using a population-based electronic health record (EHR) database in Yinzhou district, Ningbo City. Children 0-2 years of age receiving at least one dose of these vaccines between January 1, 2012 and March 31, 2017 were included in the study. Yinzhou EHR database consisted of immunization records and healthcare data of children from hospitals and community health centers in the district. Eight HOIs (i.e., anaphylaxis, febrile seizures, all seizures, asthma, apnea, Kawasaki disease [KD], urticaria/angioedema, Guillain-Barré syndrome [GBS]) were identified using ICD-10 codes. RESULTS: A total of 220,422 eligible children was identified. No cases of apnea, KD, and GBS were observed within 7 days post-vaccination. During 0-7 days post-vaccination for OPV, DTaP, Hib, and DTaP-IPV//PRP ~ T, the IRs of anaphylaxis, febrile seizures, all seizures, urticaria/angioedema and asthma ranged from 0.0 to 50.0, 0.0 to 99.9, 29.1 to 249.8, 297.8 to 949.1, and 992.7 to 2298.2 per 100,000 person-years, respectively, and 0.0 to 0.9, 0.0 to 1.9, 0.6 to 4.6, 5.6 to 17.5, and 18.7 to 42.3 per 100,000 doses, respectively. CONCLUSION: IRs of some HOIs in our study were comparable with those in the literature while IRs of other HOIs were not due to differences in study design, post-vaccination risk periods assessed, and vaccine types. Future studies should consider medical chart review for validating HOIs obtained in the EHR.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Huang K, Tao S, Zhou X, et al. Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou Electronic Health Records: A population-based retrospective cohort study. Vaccine. 2020. PMID: 32178909. doi:10.1016/j.vaccine.2020.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。